Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis

Kimmy G. Su, Gary Banker, Dennis Bourdette, Michael Forte

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a chronic disease of the central nervous system, affecting more than 2 million people worldwide. Traditionally considered an inflammatory demyelinating disease, recent evidence now points to axonal degeneration as crucial to the development of irreversible disability. Studies show that axonal degeneration occurs throughout the entire course of MS. Although the specific mechanisms causing axonal damage may differ at various stages, mitochondrial failure seems to be a common underlying theme. This review addresses the mitochondrial hypothesis for axonal degeneration in MS, highlighting the mechanisms by which mitochondrial dysfunction leads to axonal disruption in acute inflammatory lesions and the chronic axonopathy in progressive MS. Emphasis is placed on Ca2+, free radical production, and permeability transition pore opening as key players in mitochondrial failure, axonal transport impairment, and subsequent axonal degeneration. In addition, the role of mitochondria as therapeutic targets for neuroprotection in MS is addressed.

Original languageEnglish (US)
Pages (from-to)411-417
Number of pages7
JournalCurrent Neurology and Neuroscience Reports
Volume9
Issue number5
DOIs
StatePublished - 2009

Fingerprint

Multiple Sclerosis
Axonal Transport
Demyelinating Diseases
Free Radicals
Permeability
Mitochondria
Chronic Disease
Central Nervous System
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Axonal degeneration in multiple sclerosis : The mitochondrial hypothesis. / Su, Kimmy G.; Banker, Gary; Bourdette, Dennis; Forte, Michael.

In: Current Neurology and Neuroscience Reports, Vol. 9, No. 5, 2009, p. 411-417.

Research output: Contribution to journalArticle

@article{1eb1851778ec4d12b84afefb3c036546,
title = "Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis",
abstract = "Multiple sclerosis (MS) is a chronic disease of the central nervous system, affecting more than 2 million people worldwide. Traditionally considered an inflammatory demyelinating disease, recent evidence now points to axonal degeneration as crucial to the development of irreversible disability. Studies show that axonal degeneration occurs throughout the entire course of MS. Although the specific mechanisms causing axonal damage may differ at various stages, mitochondrial failure seems to be a common underlying theme. This review addresses the mitochondrial hypothesis for axonal degeneration in MS, highlighting the mechanisms by which mitochondrial dysfunction leads to axonal disruption in acute inflammatory lesions and the chronic axonopathy in progressive MS. Emphasis is placed on Ca2+, free radical production, and permeability transition pore opening as key players in mitochondrial failure, axonal transport impairment, and subsequent axonal degeneration. In addition, the role of mitochondria as therapeutic targets for neuroprotection in MS is addressed.",
author = "Su, {Kimmy G.} and Gary Banker and Dennis Bourdette and Michael Forte",
year = "2009",
doi = "10.1007/s11910-009-0060-3",
language = "English (US)",
volume = "9",
pages = "411--417",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "5",

}

TY - JOUR

T1 - Axonal degeneration in multiple sclerosis

T2 - The mitochondrial hypothesis

AU - Su, Kimmy G.

AU - Banker, Gary

AU - Bourdette, Dennis

AU - Forte, Michael

PY - 2009

Y1 - 2009

N2 - Multiple sclerosis (MS) is a chronic disease of the central nervous system, affecting more than 2 million people worldwide. Traditionally considered an inflammatory demyelinating disease, recent evidence now points to axonal degeneration as crucial to the development of irreversible disability. Studies show that axonal degeneration occurs throughout the entire course of MS. Although the specific mechanisms causing axonal damage may differ at various stages, mitochondrial failure seems to be a common underlying theme. This review addresses the mitochondrial hypothesis for axonal degeneration in MS, highlighting the mechanisms by which mitochondrial dysfunction leads to axonal disruption in acute inflammatory lesions and the chronic axonopathy in progressive MS. Emphasis is placed on Ca2+, free radical production, and permeability transition pore opening as key players in mitochondrial failure, axonal transport impairment, and subsequent axonal degeneration. In addition, the role of mitochondria as therapeutic targets for neuroprotection in MS is addressed.

AB - Multiple sclerosis (MS) is a chronic disease of the central nervous system, affecting more than 2 million people worldwide. Traditionally considered an inflammatory demyelinating disease, recent evidence now points to axonal degeneration as crucial to the development of irreversible disability. Studies show that axonal degeneration occurs throughout the entire course of MS. Although the specific mechanisms causing axonal damage may differ at various stages, mitochondrial failure seems to be a common underlying theme. This review addresses the mitochondrial hypothesis for axonal degeneration in MS, highlighting the mechanisms by which mitochondrial dysfunction leads to axonal disruption in acute inflammatory lesions and the chronic axonopathy in progressive MS. Emphasis is placed on Ca2+, free radical production, and permeability transition pore opening as key players in mitochondrial failure, axonal transport impairment, and subsequent axonal degeneration. In addition, the role of mitochondria as therapeutic targets for neuroprotection in MS is addressed.

UR - http://www.scopus.com/inward/record.url?scp=68449092498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68449092498&partnerID=8YFLogxK

U2 - 10.1007/s11910-009-0060-3

DO - 10.1007/s11910-009-0060-3

M3 - Article

C2 - 19664372

AN - SCOPUS:68449092498

VL - 9

SP - 411

EP - 417

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 5

ER -